Thus, the aim of this state-of-the-art review is to explore and discuss the interface of depression and diabetes, synthesizing evidence on therapeutic strategies that address both conditions simultaneously
The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits
J Clin Invest 2023;133:e167700.ArticlePubMedPMC 31
When combined with lab work, health history, and provider expertise, genetic context supports a more nuanced conversation about which compounded GLP-1 formulation (semaglutide, tirzepatide, microdose, or GLP-Squared) may align with your biology
Contamination Risks : If the vial is opened, bacteria or other contaminants can enter, especially if it is used past the recommended timeframe
Glucagon-like peptide-1 (GLP-1) is a peptide hormone deriving from the tissue-specific posttranslational processing of the proglucagon peptide